SCHEMBL28653165

SCHEMBL28653165

COc1ccc(COc2cc(C3Oc4cc(O)cc(O)c4C(O)C3O)cc(O)c2O)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 2/20 0.57
▸ KMT2A Q03164 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ RECQL P46063 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ SLCO1B3 Q9NPD5 2/20 0.37
▸ SLCO1B1 Q9Y6L6 2/20 0.37
▸ SLCO2B1 O94956 1/20 0.37
▸ CBS P35520 1/20 0.36
▸ MMP2 P08253 2/20 0.36
▸ MMP7 P09237 2/20 0.36
▸ MMP14 P50281 2/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ SYNJ2 O15056 1/20 0.36
▸ APP P05067 1/20 0.36
▸ SOST Q9BQB4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21738179 0.91 XDH (0.47) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21738194 0.86 XDH (0.42) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21738277 0.85 XDH (0.39) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21722685 0.84 XDH (0.44) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21738274 0.84 XDH (0.58) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21722694 0.83 XDH (0.48) XDHKMT2AMAPTMEN1SLCO1B3
SCHEMBL21722583 0.79 XDH (0.51) XDHKMT2AMAPTPOLBMEN1
SCHEMBL21722700 0.78 XDH (0.43) XDHKMT2AMAPTMEN1SLCO1B3
SCHEMBL21722777 0.78 XDH (0.64) XDHKMT2AMAPTPOLBMEN1
Leucodelphinidin SCHEMBL14374974 0.75 XDH (1.00) XDHKMT2AMAPTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110294732-B Pharmaceutical compound for treating liver diseases and application thereof 江苏新元素医药科技有限公司 2021-10-26 — — CN disclosed
Send feedback